Monte Rosa Therapeutics Inc Tangible Net Worth Ratio
Monte Rosa Therapeutics Inc tangible net worth ratio. Monte Rosa Therapeutics Inc (GLUE) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($485.05 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check GLUE strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Monte Rosa Therapeutics Inc (2021–2025)
Tangible net worth ratio of Monte Rosa Therapeutics Inc from 2021 to 2025. This chart shows how Monte Rosa Therapeutics Inc's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 100.0%, reflecting net assets of $485.05 Million with intangible assets of $0.00 USD. See Monte Rosa Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Monte Rosa Therapeutics Inc Tangible Net Worth Ratio by Year (2021–2025)
Monte Rosa Therapeutics Inc tangible net worth ratio by year from 2021 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Monte Rosa Therapeutics Inc from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Monte Rosa Therapeutics Inc (GLUE) total market value.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $233.06 Million | $0.00 | $448.66 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $222.94 Million | $0.00 | $438.73 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $179.25 Million | $0.00 | $303.75 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $271.41 Million | $0.00 | $342.39 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $347.51 Million | $0.00 | $366.33 Million | — |